ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 146 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $13,674,000 | +60.2% | 725,000 | 0.0% | 0.01% | +40.0% |
| Q2 2019 | $8,533,000 | -13.8% | 725,000 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $9,896,000 | +94.5% | 725,000 | +196.4% | 0.01% | +66.7% |
| Q1 2017 | $5,088,000 | 0.0% | 244,600 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $5,088,000 | -37.9% | 244,600 | -2.2% | 0.00% | -25.0% |
| Q3 2016 | $8,193,000 | +31.2% | 250,000 | 0.0% | 0.00% | +33.3% |
| Q2 2016 | $6,243,000 | -65.9% | 250,000 | -60.3% | 0.00% | -62.5% |
| Q4 2014 | $18,311,000 | +115.5% | 629,472 | -6.1% | 0.01% | +100.0% |
| Q3 2014 | $8,498,000 | -48.4% | 670,200 | -18.3% | 0.00% | -42.9% |
| Q2 2014 | $16,467,000 | – | 820,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,130 | $34,629,000 | 11.36% |
| Foresite Capital Management II, LLC | 1,586,220 | $18,670,000 | 10.50% |
| DAFNA Capital Management LLC | 636,013 | $7,486,000 | 2.81% |
| Redmile Group, LLC | 8,244,896 | $97,042,000 | 2.75% |
| Lion Point Capital, LP | 1,204,600 | $14,178,000 | 1.40% |
| Palo Alto Investors LP | 1,861,630 | $21,911,000 | 1.06% |
| SAMLYN CAPITAL, LLC | 3,517,856 | $41,405,000 | 0.87% |
| Bellevue Group AG | 4,118,806 | $48,478,000 | 0.83% |
| Rock Springs Capital Management LP | 1,562,300 | $18,388,000 | 0.66% |
| Artal Group S.A. | 850,000 | $10,005,000 | 0.40% |